Williams John R
World Medical Association, B.P. 63, 01212 Ferney-Voltaire Cedex, France.
Sci Eng Ethics. 2006 Jan;12(1):5-12. doi: 10.1007/pl00022264.
Responsibility for the protection of human research subjects is shared by investigators, research ethics committees, sponsors/funders, research institutions, governments and, the focus of this article, physicians who enrol patients in clinical trials. The article describes the general principles of the patient-physician relationship that should regulate the participation of physicians in clinical trials and proposes guidelines for determining when and how such participation should proceed. The guidelines deal with the following stages of the trial: when first considering participation, when deciding whether to enrol patients, when asking patients to participate, when the trial is underway and when it is completed.
保护人类研究受试者的责任由研究者、研究伦理委员会、赞助商/资助者、研究机构、政府以及(本文的重点)将患者纳入临床试验的医生共同承担。本文描述了医患关系的一般原则,这些原则应规范医生参与临床试验的行为,并提出了确定何时以及如何进行这种参与的指导方针。这些指导方针涉及试验的以下阶段:首次考虑参与时、决定是否纳入患者时、邀请患者参与时、试验进行期间以及试验完成时。